Literature DB >> 12185431

Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications.

M Meisner1, C Rauschmayer, J Schmidt, R Feyrer, R Cesnjevar, D Bredle, K Tschaikowsky.   

Abstract

OBJECTIVE: Type and frequency of postoperative abnormalities were registered after cardiovascular surgery to evaluate the aetiology and diagnostic value of increased concentrations of procalcitonin (PCT) and C-reactive protein (CRP) during the early postoperative period.
DESIGN: Prospective, observational study. PATIENTS: Two hundred and eight patients undergoing coronary artery bypass grafting or valve replacement requiring cardiopulmonary bypass were monitored for 7 days postoperatively for various types of infectious or non-infectious complications. Plasma PCT and CRP levels were measured on day 1 and day 2 after surgery and, when increased, until day 7.
RESULTS: More patients with PCT above 2 ng/ml on day 1 or 2 (n=55) had postoperative abnormalities (95%) than patients with lower PCT (59%). Specifically, the incidence of three or more criteria of the "systemic inflammatory response syndrome" was 45% versus 4% (area under the curve of the receiver operating characteristic 0.866); positive inotropic support was needed in 65% versus 9% (0.870); respiratory insufficiency (PaO(2)/FIO(2)<200) 38% versus 12% (0.704); proven and suspected bacterial infection 9% versus 1% (0.900) and 24% versus 1% (0.897), respectively. For CRP, the respective areas under the curve were all below 0.63, while all patients had elevated CRP levels, whether they had a complication or not.
CONCLUSIONS: Elevated PCT, but not CRP, correlates with evidence of systemic inflammation and other complications early postoperatively after cardiac surgery. Although the PCT levels do not rise as quickly as the criteria of the systemic inflammatory response syndrome appear, they do reflect systemic inflammation. Early identification and quantification of a systemic inflammatory response may help reduce postoperative complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185431     DOI: 10.1007/s00134-002-1392-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  Procalcitonin-guided antibiotic treatment in critically ill patients.

Authors:  Andreas Hohn; Bernhard Heising; Jan-Karl Schütte; Olaf Schroeder; Stefan Schröder
Journal:  Langenbecks Arch Surg       Date:  2016-06-10       Impact factor: 3.445

2.  Risk factors for sepsis and endocarditis and long-term survival following coronary artery bypass grafting.

Authors:  Ioannis K Toumpoulis; Constantine E Anagnostopoulos; Stavros K Toumpoulis; Joseph J De Rose; Daniel G Swistel
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

3.  Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery.

Authors:  Serdar Celebi; Ozge Koner; Ferdi Menda; Huriye Balci; Alican Hatemi; Kubilay Korkut; Figen Esen
Journal:  Intensive Care Med       Date:  2006-04-28       Impact factor: 17.440

Review 4.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

5.  Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery.

Authors:  F Kerbaul; F Collart; R Giorgi; C Oddoze; P J Lejeune; C Guidon; T Caus; M Bellezza; F Gouin
Journal:  Intensive Care Med       Date:  2004-04-27       Impact factor: 17.440

6.  C-Reactive Protein and Procalcitonin as Predictors of Postoperative Inflammatory Complications After Pancreatic Surgery.

Authors:  A Giardino; G Spolverato; P Regi; I Frigerio; F Scopelliti; R Girelli; Z Pawlik; P Pederzoli; C Bassi; G Butturini
Journal:  J Gastrointest Surg       Date:  2016-05-20       Impact factor: 3.452

7.  Procalcitonin in preoperative diagnosis of abdominal sepsis.

Authors:  Nenad Ivancević; Dejan Radenković; Vesna Bumbasirević; Aleksandar Karamarković; Vasilije Jeremić; Nevena Kalezić; Tatjana Vodnik; Biljana Beleslin; Natasa Milić; Pavle Gregorić; Milos Zarković
Journal:  Langenbecks Arch Surg       Date:  2007-10-30       Impact factor: 3.445

8.  Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations.

Authors:  Bertrand Delannoy; Marie-Laurence Guye; Davy Hay Slaiman; Jean-Jacques Lehot; Maxime Cannesson
Journal:  Crit Care       Date:  2009-11-13       Impact factor: 9.097

9.  Relevance of Endothelial Cell-Specific Molecule 1 (Endocan) Plasma Levels for Predicting Pulmonary Infection after Cardiac Surgery in Chronic Kidney Disease Patients: The Endolung Pilot Study.

Authors:  Andréa Perrotti; Camille Chenevier-Gobeaux; Fiona Ecarnot; Benoit Barrucand; Philippe Lassalle; Enrica Dorigo; Sidney Chocron
Journal:  Cardiorenal Med       Date:  2017-08-31       Impact factor: 2.041

10.  Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.

Authors:  C Picariello; C Lazzeri; M Chiostri; G F Gensini; S Valente
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.